Position in JANX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$636,349
+$338,055 QoQ
Shares Held
41,429
+93.1% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 198 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jain Global LLC holds $158,466,048 across 104 Biotechnology names. JANX ranks #37 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
18,913 | $17,546,914 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
486,186 | $17,206,122 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,686 | $16,763,156 | |
| 4 | MRNA |
Moderna, Inc.
|
181,264 | $12,693,917 | |
| 5 | INSM |
INSMED Inc
|
111,204 | $11,856,570 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
27,569 | $6,748,064 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,965 | $5,887,656 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
61,895 | $5,045,061 |
All Filings in JANX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $636,349 | 41,429 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $298,294 | 21,460 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $240,587 | 9,844 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||